Sponsors
Piper Jaffray
Piper Jaffray Ltd. is a leading investment bank servicing the UK small/mid-cap health care sector. The firm is the retained financial adviser and/or broker to 55% of the companies comprising the techMARK mediscience index. Piper Jaffray Ltd. makes markets in over 28 LSE full and AIM-listed health care stocks, has research coverage of 50 European health care stocks and the ability to distribute this research product both in Europe and in the United States. The firm has extensive experience in the health care and technology sectors.
Having been involved in 11 of the top 30 European biotech equity financing transactions (six as bookrunner) since the beginning of 2006, Piper Jaffray Ltd. has raised more money for European biotech companies than any other investment bank. Over the same period, the firm was responsible for over 50% of all secondary equity financing raised in the UK biotech sector. Piper Jaffray Ltd. has advised on 16 M&A transactions since the beginning of 2006, 14 of which were cross-border.
Piper Jaffray Ltd. is a subsidiary of Piper Jaffray Companies, a leading, international middle market investment bank and NYSE-listed institutional securities firm with a market cap of c. US$600 million. It offers investment banking, equity research and equity sales and trading within Europe to middle market corporations, private equity groups and institutional investors. Piper Jaffray Ltd. is authorised and regulated by the Financial Services Authority and is a member of the London Stock Exchange.
Piper Jaffray is proud to sponsor the European mediscience awards dinner.
For further information: www.piperjaffray.co.uk
BioIndustry Association
The BioIndustry Association (BIA) actively represents the interests of its 300 members, from the UK bioscience community, to a broad range of stakeholders. It promotes the human health benefits of the UK's innovative research and development base, both nationally and internationally. Members benefit from preferential, discounted attendance at exclusive BIA events designed to stimulate, inform and spread industry best practice.
Headquartered in London, the BIA also has an office in Edinburgh to serve the interests of our Scottish members.
For further information: www.bioindustry.org
NASDAQ OMX Group
The NASDAQ OMX Group, Inc. is the world's largest exchange company. It delivers trading, exchange technology and public company services across six continents, with over 3,700 listed companies. NASDAQ OMX offers multiple capital raising solutions to companies around the globe, including its U.S. listings market, NASDAQ OMX Nordic, NASDAQ OMX Baltic, NASDAQ OMX First North, and the U.S. 144A sector. The company offers trading across multiple asset classes including equities, derivatives, debt, commodities, structured products and exchange-traded funds. NASDAQ OMX technology supports the operations of over 70 exchanges, clearing organizations and central securities depositories in more than 50 countries.
NASDAQ OMX Nordic and NASDAQ OMX Baltic are not legal entities but describe the common offering from NASDAQ OMX exchanges in Helsinki, Copenhagen, Stockholm, Iceland, Tallinn, Riga, and Vilnius.
For more information about NASDAQ OMX, visit http://www.nasdaqomx.com. Please follow NASDAQ OMX on Facebook and Twitter
Buchanan Communications
Buchanan Communications is a leading City financial public relations agency with a particular specialism in the life science arena. The agency has built up an exciting and diverse client portfolio ranging from profitable pharmaceutical companies through to platform and drug discovery companies. Currently Buchanan advises more than 40 life science clients. The Buchanan life science team is headed up by Tim Anderson, a founder of Buchanan Communications, with each of the key partners and directors in the team having over ten years' direct experience of the life science sector.
For further information: www.buchanan.uk.com
MATRIX Corporate Capital LLP
Matrix Corporate Capital LLP (MCC) is part of the Matrix Group (Matrix Group) and offers clients integrated Corporate Finance, Broking, Market Making and Research services, differentiating ourselves by ensuring that our high standards of integrity and responsiveness are backed up by thorough in-depth research provided by analysts with strong industry backgrounds.
In addition to the services offered by MCC, Matrix Group has raised over £100 million for listed and unlisted biotechnology companies. Amongst other sectors, Matrix has a particular interest in the pharmaceutical and biotechnology sectors through its life sciences investments (supporting six companies internally) based in London and Cambridge and is underpinned by its in house medical team. This provides our clients with unrivalled support and industry knowledge of their businesses thereby enabling us to provide objective and informed advice.
Our services include:
- Corporate Finance - capital fund raisings for quoted and unquoted companies, mergers and acquisitions advisory, general corporate advisory
- Corporate Broking - providing clients with access to institutional and other investors for primary and secondary fund raisings
- Research - broad sector coverage including the pharmaceutical/biotechnology, building, clean technology, food producers, household & personal care, investment companies, mining & metals, new energy, oil & gas, power and tobacco sectors
- Investment Funds - specialist team providing corporate finance, research, secondary trading and market making for Investment Companies
- Market Making & Secondary Trading - active in the secondary markets in stocks of all sizes and making markets in our corporate clients
Matrix Corporate Capital LLP is authorised and regulated by the Financial Services Authority and is a member of the London Stock Exchange. We are a Nominated Broker and Nominated Adviser (NOMAD) to AIM.
MCC is delighted to be sponsoring the breakthrough of the year award.
For further information: http://www.matrixgroup.co.uk/corporate_capital
Corfin Communications
Corfin Communications specialises in media relations, financial PR and corporate communications for companies listed in London or those seeking a higher profile in London’s financial centre. Corfin is capable of delivering an effective communications strategy for clients across a wide range, by sector and size. At Corfin we have a complementary skill-set of team that has extensive experience of working with chief executives, finance directors and corporate advisers. We have a deep understanding of the media and financial markets and are able to devote a high level of personal attention, time and commitment to our clients.
Menu Sponsor
M:Communications
M:Communications was founded in 2002 and has quickly become Europe's most sought after financial and corporate communications agency. M:, with a global network of offices in London, New York, Dubai and Hong Kong, has represented some of the world's most successful international businesses and in particular, in Europe, has served or is retained by 60 of the EURO300. M:'s highly experienced senior consultants advise clients across a whole range of corporate and financial communications including reputation management, profile raising, media management, transactions, investor relations and crisis response.
M:'s sector specialist healthcare team has more than fifteen years of experience from the pharmaceutical industry and leading communications agencies. The team is highly experienced in working alongside international healthcare clients, both public and private, across the entire range of sub-sectors. M: prides itself on providing a high quality and proactive approach to clients and has quickly become established as a leading healthcare consultancy.
The healthcare team at M: is pleased to be sponsoring this year's European Mediscience Awards Dinner and we hope you enjoy the evening.
For more information please visit www.mcomgroup.com or send an e-mail to healthcare@mcomgroup.com.